Drugs that fight cancer ... naturally. (biological response modifiers)Bennett, Dawn D
breastand lung tumors. There's even a "uni-drug" that may fight many forms of the disease. What's especially striking: The drugs are beneficial in some cases for more than a year, much longer than the few months many new drugs provide....
Anthracycline chemotherapy attacks the enzymes inside cancer cells’ DNA that help them divide and grow. They work for many types of cancer. Some of these drugs are actinomycin-D,bleomycin,daunorubicin, anddoxorubicin, among others. High doses of anti-tumor antibiotics can damage your heart or lu...
ChromosomesSex ChromosomesAnimalsDrosophila melanogasterChromosome MappingRadiation DosageHybridization, GeneticRadiation GeneticsHeterozygoteNo abstract is available for this article.doi:10.1002/scin.2014.186013005SeppaNathanJohn Wiley & Sons, Ltd.Science News...
Triple-negativebreast cancer (TNBC), an aggressive subtype ofbreast cancer, is difficult to be targeted therapeutically due tonegative expression of the bioreceptor, which leads to the poorestoverall four-year survival rate among all cancer subtypes. We proposedthat the nanomedicine featuring high payl...
Nitrogen mustards were developed in the 1920s and ’30s as agents of chemical warfare. By the 1940s, however, it had become clear that at least one of these compounds, HN-2, also known as mechlorethamine, was better suited for use in the fight against cancer, specifically against human...
mutation–n.a genetic change that, in the case of cancer, results in irregular cells immune system–n.the system of cells and substances in the body that fight infection and sickness clinical trial—n.tests that are done on r...
According to a study published in the Journal of Natural Products, Swedish researchers have found that cardiac glycosides show promise for fighting colon cancer. This group of naturally derived drugs is used to treat congestive heart failure and cardiac arrhythmias. The scientists tested five glycosides...
A DYING cancer patient is going to court in a last-ditch fight for a drug that will prolong his life, the Standard can reveal today. The move by bowel cancer victim Michael Porter is the latest challenge to the NHS over top-up drugs. The public battle is set to pile pressure on ...
The cost of cracking cancer The Covid-era tech that could reinvent cancer care Pandemic winners BioNTech and Moderna face hurdles as they seek to bring their groundbreaking technology to oncology Dementia Patients on diabetes drugs less likely to develop dementia, research finds ...